by Baylor College of Medicine Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia The battle against late-stage prostate cancer might have found a potential new strategy to combat this deadly disease. Research led by Baylor College of Medicine reveals in the Journal of Clinical Investigation that the enzyme MAPK4 concertedly activates androgen receptor (AR)...
February 15th 2021, Posted by IAN DEMSKY-MICHIGAN The test could have possibly avoided one third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study of more than 1,500 patients. The MyProstateScore test measures levels of cancer-specific genes in a patient’s urine. It’s based on...
JOHNS HOPKINS MEDICINE A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers. Researchers studied prostate cancer samples from 352 participants in the NRG/RTOG 9601clinical trial, which compared radiation therapy alone with...
IMPACT JOURNALS LLC IMAGE: OVERALL SURVIVAL CURVES OF PATIENTS WITH POOR PROGNOSIS PCA DEPENDING ON THE INTAKE OF MELATONIN (LOG RANK TEST < 0.0001). CREDIT: CORRESPONDENCE TO – VLADIMIR N. ANISIMOV – [email protected] Oncotarget recently published “Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment” which reported that a retrospective study included...
by Northwestern University Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits from immunotherapy treatment. A new Northwestern Medicine study discovered the reason appears to be an increase of a surprising type of immune cell in the...
HONG KONG BAPTIST UNIVERSITY IMAGE: PROFESSOR GARY WONG (MIDDLE), PROFESSOR NG CHI-FAI (RIGHT) AND DR PETER CHIU (LEFT) HAVE JOINTLY DEVELOPED THE SPERMINE RISK SCORE WHICH PROVIDES A NON-INVASIVE AND MORE RELIABLE METHOD FOR THE DIAGNOSIS OF PROSTATE CANCER. CREDIT: HONG KONG BAPTIST UNIVERSITY Researchers from Hong Kong Baptist University (HKBU) and the Faculty of Medicine...
by Ontario Institute for Cancer Research Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia The results of a Phase III randomized clinical trial have shown that when it comes to detecting clinically significant prostate cancer, Magnetic Resonance Imaging (MRI) with targeted biopsies (MRI-TBx) matches the current standard and brings a multitude of advantages....
By RYAN MORRISON FOR MAILONLINE PUBLISHED: 06:24 EST, 28 January 2021 | UPDATED: 10:21 EST, 28 January 2021 A new non-invasive treatment for prostate cancer is the ‘single biggest change in 20 years’ and can prevent side-effects related to surgery, a new study found. Researchers from Imperial College London studied the results of over 500 patient given the treatment – named focal therapy –...
by Thomas Jefferson University Cancer cell during cell division. Credit: National Institutes of Health Our biological or circadian clock synchronizes all our bodily processes to the natural rhythms of light and dark. It’s no wonder then that disrupting the clock can wreak havoc on our body. In fact, studies have shown that when circadian rhythms are...
UNIVERSITY OF CALIFORNIA – LOS ANGELES HEALTH SCIENCES FINDINGS A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment. The study authors found that such underestimation occurs most often when the MRI-measured tumor size...
